Cite
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS
MLA
Castresana, Javier S., et al. Acquired Resistance to Oxaliplatin Is Not Directly Associated with Increased Resistance to DNA Damage in SK-N-ASrOXALI4000, a Newly Established Oxaliplatin-Resistant Sub-Line of the Neuroblastoma Cell Line SK-N-AS. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1362790099&authtype=sso&custid=ns315887.
APA
Castresana, J. S., Saintas, E., Abrahams, L., Ahmad, G. T., Ajakaiye, A.-O. M., AlHumaid, A. S. H. A. M., Ashmore-Harris, C., Clark, I., Dura, U. K., Fixmer, C. N., Ike-Morris, C., Prado, M. M., Mccullough, D., Mishra, S., Schöler, K. M. U., Timur, H., Williamson, M. D. C., Alatsatianos, M., Bahsoun, B., … Michaelis, M. (2017). Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS.
Chicago
Castresana, Javier S., Emily Saintas, Liam Abrahams, Gulshan T. Ahmad, Anu-Oluwa M. Ajakaiye, Abdulaziz S. H. A. M. AlHumaid, Candice Ashmore-Harris, et al. 2017. “Acquired Resistance to Oxaliplatin Is Not Directly Associated with Increased Resistance to DNA Damage in SK-N-ASrOXALI4000, a Newly Established Oxaliplatin-Resistant Sub-Line of the Neuroblastoma Cell Line SK-N-AS.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1362790099&authtype=sso&custid=ns315887.